Prevalence and Impact of Lupus Anticoagulant in Patients Receiving Extracorporeal Membrane Oxygenation

BACKGROUND: Monitoring of blood coagulation is essential in ECMO patients. We investigated the prevalence of lupus anticoagulant (LA) and its association with coagulation testing and hemostaseologic complications in patients treated with ECMO. METHODS: This is a retrospective analysis including adul...

Descripción completa

Detalles Bibliográficos
Autores principales: Kornfehl, Andrea, Brock, Roman, Staudinger, Thomas, Schellongowski, Peter, Nagler, Bernhard, Hermann, Alexander, Robak, Oliver, Schwameis, Michael, Quehenberger, Peter, Buchtele, Nina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Manuscript
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588400/
https://www.ncbi.nlm.nih.gov/pubmed/37853541
http://dx.doi.org/10.1177/10760296231207062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588400/
https://www.ncbi.nlm.nih.gov/pubmed/37853541
http://dx.doi.org/10.1177/10760296231207062

Ejemplares similares